New Delhi, Jan. 8 -- Listed healthcare companies are expected to deliver strong growth in the third quarter of FY26, supported by robust performance across hospitals, diagnostics and pharmacy segments, highlighted a report by Nuvama.

According to the report, the overall healthcare coverage is projected to see EBITDA expansion of around 22 per cent year-on-year in Q3FY26, driven primarily by a similar 22 per cent growth in hospitals and diagnostics.

Despite Q3 being a seasonally soft quarter for hospitals, the sector is expected to maintain healthy growth momentum on the back of structural drivers.

It stated "We expect Q3FY26E EBITDA of our healthcare coverage to expand approx. 22 per cent YoY propelled by approx. 22 per cent growth in ...